May 2026 Roche Diagnostics strengthened its immunoassay testing capabilities through advancements in automated diagnostic platforms supporting thyroid function testing. The initiatives focused on improving laboratory workflow, test reliability, and early detection of thyroid disorders.
April 2026 Siemens Healthineers expanded its laboratory diagnostics portfolio by enhancing immunoassay technologies used for thyroid testing. The company focused on improving automation, scalability, and integration of diagnostic systems across healthcare facilities.
January 2026 Thermo Fisher Scientific expanded its clinical diagnostics capabilities through investments in laboratory automation and immunodiagnostic technologies. The initiatives supported improved testing efficiency for endocrine and thyroid-related conditions.
November 2025 Danaher strengthened its diagnostics ecosystem through continued development of advanced immunoassay platforms across its operating companies. The initiatives supported improved clinical testing workflows, including thyroid hormone measurement applications.